Frequency News and Research

RSS

Philips ushers new era in radiology science with Imaging 2.0 technology at RSNA annual meeting

This year at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.

From Philips Healthcare 29 Nov 2010

Philips Electronics showcases first-ever digital broadband MRI solution at RSNA annual meeting

Today at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics showcased Philips Ingenia, the first-ever digital broadband magnetic resonance imaging (MRI) solution.

29 Nov 2010

Canadian Red Cross announces First Responder Initiative for disaster response

The Canadian Red Cross is pleased to announce the First Responder Initiative, which increases the Red Cross' capacity to prepare for and rapidly respond to disasters and includes the ability to quickly deploy tented field hospitals.

26 Nov 2010

Public health: Frequency of dialysis treatment questioned, chemotherapy drug shortages

A new study funded by the National Institutes of Health suggests that receiving dialysis six days a week results in better self-reported patient health than the conventional treatment of three times per week.

25 Nov 2010

New NIVI tissue-imaging technique can accurately detect cancer cells

The long, anxious wait for biopsy results could soon be over, thanks to a tissue-imaging technique developed at the University of Illinois.

25 Nov 2010

Magnetic fluid hyperthermia destroys cells inside tumors

Magnetic fluid hyperthermia (MFH) is a promising new cancer treatment that essentially "fries" cells inside tumors. The procedure has been used successfully in prostate, liver, and breast tumors.

24 Nov 2010

New method to target and destroy cancerous cells using hyperthermia

Using hyperthermia, Virginia Tech engineering researchers and a colleague from India unveiled a new method to target and destroy cancerous cells. The research was presented at the 63rd annual meeting of the American Physical Society Nov. 23 in Long Beach, Calif.

23 Nov 2010

Researchers unveil new method to target and destroy cancerous cells

23 Nov 2010

New computer method measures mechanical stress in fat cells

From fad diets to exercise programs, Americans continue to fight the battle of the bulge. Now they'll have help from recent Tel Aviv University research that has developed a new method to look at how fat cells which produce the fat in our bodies respond to mechanical loads.

23 Nov 2010

New simple diagnostic tool to detect dangerous viruses

Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor, which is the size of a quarter and can detect viruses in a blood sample, could be used in developing nations, airports and other places where natural or man-made outbreaks could erupt.

22 Nov 2010

Bardoxolone methyl treatment may reduce stage of CKD, improve eGFR in kidney function

Reata Pharmaceuticals and Abbott today announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic kidney disease (CKD), may reduce the stage of CKD and improve estimated glomerular filtration rate (eGFR) and other measures of kidney function in the majority of patients receiving the drug.

22 Nov 2010

German researchers use binocular rivalry to interpret mechanism of brain functions

Researchers around Andreas Bartels at the Werner Reichardt Centre for Integrative Neurosciences (CIN) and the Max Planck Institute for Biological Cybernetics in Tübingen, Germany used this phenomenon to decipher a key mechanism of the brain functions that contributes to conscious visual perception.

20 Nov 2010

ENERCA network organizes European Symposium on rare anemias

It is estimated that rare diseases -those whose frequency is under 5 cases / 10,000 people- affect about 6% of the European population. In the field of anemia, 1% of couples are at risk of having a newborn with a severe syndrome of hemoglobin. More than 330,000 children are born worldwide each year affected by one of these diseases, being the most common disorders sickle cell anemia and thalassemia syndromes.

19 Nov 2010

Caprini Risk Model helps predict VTE risk in patients undergoing plastic surgery

Patients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given clot-preventing medications after surgery.

19 Nov 2010

NAVISTAR THERMOCOOL Catheter improves quality of life in patients with atrial fibrillation

According to data appearing today in Circulation Cardiovascular Quality and Outcomes, patients with a common heart rhythm disorder, called atrial fibrillation, who were treated with catheter ablation using the NAVISTAR THERMOCOOL Catheter, reported markedly fewer symptoms and substantially improved quality of life than patients treated with antiarrhythmia drugs at one year.

18 Nov 2010

Neural differences may help explain prevalence of mental disorders in boys

Many mental health disorders, such as autism and schizophrenia, produce changes in social behavior or interactions. The frequency and/or severity of these disorders is substantially greater in boys than girls, but the biological basis for this difference between the two sexes is unknown.

18 Nov 2010

Study finds Hispanic children are susceptible to develop fatty liver disease

Two studies from the Childhood Obesity Research Center at the Keck School of Medicine of the University of Southern California (USC) have found evidence that Hispanic children and adolescents are genetically predisposed to developing fatty liver disease a condition that can lead to cirrhosis, cardiovascular disease and diabetes.

18 Nov 2010

VX-770 drug candidate improves lung function in people with cystic fibrosis

In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis (CF). There were no discontinuations due to adverse events in the study, and the frequency of adverse events was similar across the study groups.

18 Nov 2010

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Sangamo BioSciences, Inc. announced today the presentation of Phase 2 clinical data from its ZFP Therapeutic program to develop SB-509, a zinc finger protein transcriptional activator (ZFP-TF) of the vascular endothelial growth factor (VEGF)-A gene as a treatment for ALS.

17 Nov 2010

Targeted therapies could treat a broad range of cancers: Research

Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range of cancers than previously thought, according to new research presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin.

17 Nov 2010

Frequency News and Research

Philips ushers new era in radiology science with Imaging 2.0 technology at RSNA annual meeting

Philips Electronics showcases first-ever digital broadband MRI solution at RSNA annual meeting

Canadian Red Cross announces First Responder Initiative for disaster response

Public health: Frequency of dialysis treatment questioned, chemotherapy drug shortages

New NIVI tissue-imaging technique can accurately detect cancer cells

Magnetic fluid hyperthermia destroys cells inside tumors

New method to target and destroy cancerous cells using hyperthermia

Researchers unveil new method to target and destroy cancerous cells

New computer method measures mechanical stress in fat cells

New simple diagnostic tool to detect dangerous viruses

Bardoxolone methyl treatment may reduce stage of CKD, improve eGFR in kidney function

German researchers use binocular rivalry to interpret mechanism of brain functions

ENERCA network organizes European Symposium on rare anemias

Caprini Risk Model helps predict VTE risk in patients undergoing plastic surgery

NAVISTAR THERMOCOOL Catheter improves quality of life in patients with atrial fibrillation

Neural differences may help explain prevalence of mental disorders in boys

Study finds Hispanic children are susceptible to develop fatty liver disease

VX-770 drug candidate improves lung function in people with cystic fibrosis

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Targeted therapies could treat a broad range of cancers: Research

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News